Prostate development and growth in benign prostatic hyperplasia

Differentiation

Volumn 82, Issue 4-5, 2011, Pages 173-183

  Timms, Barry G ^a   Hofkamp, Luke E ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Benign prostatic hyperplasia; Branching morphogenesis; Primary cilia; Prostate development

Indexed keywords

ALPHA 1A ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANDROSTANOLONE; DUTASTERIDE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FINASTERIDE; GONADORELIN DERIVATIVE; INSULIN; PHYTOESTROGEN; SONIC HEDGEHOG PROTEIN; STEROID 5ALPHA REDUCTASE INHIBITOR; TESTOSTERONE;

AGING; CARDIOTOXICITY; CASTRATION; CELL INTERACTION; DIET SUPPLEMENTATION; EPITHELIAL MESENCHYMAL TRANSITION; FETUS DEVELOPMENT; HUMAN; HYPERINSULINEMIA; HYPOGONADISM; LOWER URINARY TRACT SYMPTOM; MESENCHYME; METABOLIC SYNDROME X; NONHUMAN; ORGAN GROWTH; ORGANOGENESIS; PATHOGENESIS; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROSTATECTOMY; REVIEW; SIGNAL TRANSDUCTION; STROMA; TRANSURETHRAL RESECTION;

AGED; ANDROGENS; CILIA; DISEASE SUSCEPTIBILITY; EPITHELIAL CELLS; HEDGEHOG PROTEINS; HUMANS; INSULIN; MALE; MESODERM; PROSTATE; PROSTATIC HYPERPLASIA; SIGNAL TRANSDUCTION; STROMAL CELLS; TUMOR MICROENVIRONMENT;

ANIMALIA;

EID: 80053000072     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2011.08.002     Document Type: Review

References (144)

1. Adams M., Smith U.M., Logan C.V., Johnson C.A. Recent advances in the molecular pathology, cell biology and genetics of ciliopathies. Jouurnal of Medical Genetics 2008, 45:257-267.
2. Aggarwal S., Thareja S., Verma A., Bhardwaj T.R., Kumar M. An overview on 5alpha-reductase inhibitors. Steroids 2010, 75:109-153.
3. Alonso-Magdalena P., Brossner C., Reiner A., Cheng G., Sugiyama N., Warner M., Gustafsson J.A. A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia. Proceedings of the National Acadamy of Sciences USA 2009, 106:2859-2863.
4. Aumuller G. Prostate Gland and Seminal Vesicles. Handbuch der Mikroskopischen Anatomie des Menschen 1979, Springer-Verlag, Berlin-Heidelberg-New York. A. Oksche, L. Vollrath (Eds.).
5. Aumuller G., Adler G. Experimental studies of apocrine secretion in the dorsal prostate epithelium of the rat. Cell and Tissue Research 1979, 198:145-158.
6. Bonkhoff H., Berges R. The evolving role of oestrogens and their receptors in the development and progression of prostate cancer. European Urology 2009, 55:533-542.
7. Born G. Die Plattenmodellirmethode. Archive fur Mikroskopische Anatomie 1883, 22:584-599.
8. Breunig J.J., Sarkisian M.R., Arellano J.I., Morozov Y.M., Ayoub A.E., Sojitra S., Wang B., Flavell R.A., Rakic P., Town T. Primary cilia regulate hippocampal neurogenesis by mediating sonic hedgehog signaling. Proceedings of the National Acadamy of Sciences USA 2008, 105:13127-13132.
9. Brodie B. Lectures on The Diseases of The Urinary Organs 1843, Lea & Blanchard, Philadelphia, PA.
10. Brossner C., Petritsch K., Fink K., Auprich M., Madersbacher S., Adlercreutz H., Rehak P., Petritsch P. Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases. Urology 2004, 64:707-711.
11. Bushman W. Etiology, epidemiology, and natural history of benign prostatic hyperplasia. Urologic Clinics of North America 2009, 36:403-415. v.
12. Chen M., Tanner M., Levine A.C., Levina E., Ohouo P., Buttyan R. Androgenic regulation of hedgehog signaling pathway components in prostate cancer cells. Cell Cycle 2009, 8:149-157.
13. Cheng S.Y., Yue S. Role and regulation of human tumor suppressor SUFU in Hedgehog signaling. Advances in Cancer Research 2008, 101:29-43.
14. Christensen S.T., Ott C.M. Cell signaling. A ciliary signaling switch. Science 2007, 317:330-331.
15. Chung L.W., Baseman A., Assikis V., Zhau H.E. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. The Journal of Urology 2005, 173:10-20.
16. Colombel M.C., Buttyan R. Hormonal control of apoptosis: the rat prostate gland as a model system. Methods in Cell Biology 1995, 46:369-385.
17. Cunha G.R. Mesenchymal-epithelial interactions: past, present, and future. Differentiation 2008, 76:578-586.
18. Cunha G.R., Foster B., Thomson A., Sugimura Y., Tanji N., Tsuji M., Terada N., Finch P.W., Donjacour A.A. Growth factors as mediators of androgen action during the development of the male urogenital tract. World Journal of Urology 1995, 13:264-276.
19. Cunha G.R., Ricke W., Thomson A., Marker P.C., Risbridger G., Hayward S.W., Wang Y.Z., Donjacour A.A., Kurita T. Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development. Journal of Steroid Biochemistry and Molecuar Biology 2004, 92:221-236.
20. D'Angelo A., Franco B. The dynamic cilium in human diseases. Pathogenetics 2009, 2:3.
21. Davenport J.R., Yoder B.K. An incredible decade for the primary cilium: a look at a once-forgotten organelle. American Journal of Physiology-Renal Physiology 2005, 289:F1159-1169.
22. Diamanti-Kandarakis E., Bourguignon J.P., Giudice L.C., Hauser R., Prins G.S., Soto A.M., Zoeller R.T., Gore A.C. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocrine Reviews 2009, 30:293-342.
23. Djavan B., Eckersberger E., Finkelstein J., Espinosa G., Sadri H., Brandner R., Shah O., Lepor H. Benign prostatic hyperplasia: current clinical practice. Primary Care 2010, 37:583-597. ix.
24. Eggenschwiler J.T., Anderson K.V. Cilia and developmental signaling. Annual Review of Cell and Developmental Biology 2007, 23:345-373.
25. Ellem S.J., Risbridger G.P. The dual, opposing roles of estrogen in the prostate. Annals of the New York Acadamy of Sciences 2009, 1155:174-186.
26. Evans G.S., Chandler J.A. Cell proliferation studies in rat prostate. I. The proliferative role of basal and secretory epithelial cells during normal growth. Prostate 1987, 10:163-178.
27. Evans G.S., Chandler J.A. Cell proliferation studies in the rat prostate: II. The effects of castration and androgen-induced regeneration upon basal and secretory cell proliferation. Prostate 1987, 11:339-351.
28. Evatt E.J. A contribution to the development of the prostate in man. Journal of Anatomy and Physiology 1908, 43.
29. Fan L., Pepicelli C.V., Dibble C.C., Catbagan W., Zarycki J.L., Laciak R., Gipp J., Shaw A., Lamm M.L., Munoz A., Lipinski R., Thrasher J.B., Bushman W. Hedgehog signaling promotes prostate xenograft tumor growth. Endocrinology 2004, 145:3961-3970.
30. Fibbi B., Penna G., Morelli A., Adorini L., Maggi M. Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. International Journal of Andrology 2010, 33:475-488.
31. Fischer E., Legue E., Doyen A., Nato F., Nicolas J.F., Torres V., Yaniv M., Pontoglio M. Defective planar cell polarity in polycystic kidney disease. Nature Genetics 2006, 38:21-23.
32. Fliegauf M., Benzing T., Omran H. When cilia go bad: cilia defects and ciliopathies. Nature Reviews Molecular Cell Biology 2007, 8:880-893.
33. Franks L.M. Benign nodular hyperplasia of the prostate; a review. Annals of the Royal College Surgeons of Englang 1953, 14:92-106.
34. Franks L.M. Atrophy and hyperplasia in the prostate proper. Journal of Pathology and Bacteriology 1954, 68:617-621.
35. van Gulik T.M., Schoots I. Anastomosis of riolan revisited: the meandering mesenteric artery. Archives of Surgery 2005, 140:1225-1229.
36. Hammarsten J., Damber J.E., Karlsson M., Knutson T., Ljunggren O., Ohlsson C., Peeker R., Smith U., Mellstrom D. Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia. Prostate Cancer and Prostatic Disease 2009, 12:160-165.
37. Hannema S.E., Hughes I.A. Regulation of Wolffian duct development. Hormone Research 2007, 67:142-151.
38. Haycraft C.J., Banizs B., Aydin-Son Y., Zhang Q., Michaud E.J., Yoder B.K. Gli2 and Gli3 localize to cilia and require the intraflagellar transport protein polaris for processing and function. PLoS Genetics 2005, 1:e53.
39. Heindel J.J. Role of exposure to environmental chemicals in the developmental basis of reproductive disease and dysfunction. Seminars in Reproductive Medicine 2006, 24:168-177.
40. Ho C.K., Habib F.K. Estrogen and androgen signaling in the pathogenesis of BPH. Nature Reviews Urology 2011, 8:29-41.
41. Hofkamp L., Bradley S., Tresguerres J., Lichtensteiger W., Schlumpf M., Timms B.G. Region-specific growth effects in the developing rat prostate following fetal exposure to estrogenic UV filters. Environmental Health Perspectives 2008, 116:867-872.
42. Hofkamp L.E. Identification of novel subsets of high grade prostate intraepithelial neoplasia [HGPIN] and analysis of the distribution of suppressor of fused [SuFu] during the cell cycle. Division of Basic Biomedical Sciences 2011, The University of South Dakota, Vermillion.
43. Hofkamp L.E., Bradley S., Geliebter J., Timms B.G. Atypical fetal prostate development is associated with ipsilateral hypoplasia of the Wolffian ducts in the ACI rat. Anatomical Record (Hoboken) 2010.
44. Hong S.J., Kim S.I., Kwon S.M., Lee J.R., Chung B.C. Comparative study of concentration of isoflavones and lignans in plasma and prostatic tissues of normal control and benign prostatic hyperplasia. Yonsei Medical Journal 2002, 43:236-241.
45. Huggins C., Clark P.J. Quantitative studies of prostatic secretion: I. The effect of castration and of estrogen injection on the normal and on the hyperplastic prostate glands of dogs. Journal of Experimental Medicine 1940, 72:747-762.
46. Huggins C., Stevens R.E. The effect of castration on benign hypertorphy of the prostate in man. Journal of Urology 1940, 43:705-714.
47. Huggins C., Webster W.O. Duality of human prostate in response to estrogen. J Urol 1948, 59:258-266.
48. Hunter J. Observations on Certain Parts of the Animal Economy 1786.
49. Hyman J.M., Firestone A.J., Heine V.M., Zhao Y., Ocasio C.A., Han K., Sun M., Rack P.G., Sinha S., Wu J.J., Solow-Cordero D.E., Jiang J., Rowitch D.H., Chen J.K. Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:14132-14137.
50. Ichihara I., Pelliniemi L.J. Ultrastructure of the basal cell and the acinar capsule of rat ventral prostate. Anatomischer Anzeiger 1975, 138:355-364.
51. Isaacs J.T. Prostate stem cells and benign prostatic hyperplasia. The Prostate 2008, 68:1025-1034.
52. Isaacs J.T., Coffey D.S. Etiology and disease process of benign prostatic hyperplasia. Prostate 1989, 2:33-50. Suppl.
53. Jin B., Conway A.J., Handelsman D.J. Effects of androgen deficiency and replacement on prostate zonal volumes. Clinical Endocrinology (Oxford) 2001, 54:437-445.
54. Johnson F.P. The later development of the urethra in the male. J Urol 1920, 4.
55. Karlou M., Tzelepi V., Efstathiou E. Therapeutic targeting of the prostate cancer microenvironment. Nature reviews Urology 2010, 7:494-509.
56. Kiprilov E.N., Awan A., Desprat R., Velho M., Clement C.A., Byskov A.G., Andersen C.Y., Satir P., Bouhassira E.E., Christensen S.T., Hirsch R.E. Human embryonic stem cells in culture possess primary cilia with hedgehog signaling machinery. Journal of Cell Biology 2008, 180:897-904.
57. Kovacs J.J., Whalen E.J., Liu R., Xiao K., Kim J., Chen M., Wang J., Chen W., Lefkowitz R.J. Beta-arrestin-mediated localization of smoothened to the primary cilium. Science 2008, 320:1777-1781.
58. Kramer G., Mitteregger D., Marberger M. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?. European Urology 2007, 51:1202-1216.
59. Kumar V.L., Dewan S. Alpha adrenergic blockers in the treatment of benign hyperplasia of the prostate. International Urology and Nephrology 2000, 32:67-71.
60. Kyprianou N. Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance. Journal of Urology 2003, 169:1520-1525.
61. LeDuc I.E. The anatomy of the prostate and the pathology of early benign hypertrophy. Journal of Urology 1939, 42:1217-1241.
62. Leav I., Ho S.M., Ofner P., Merk F.B., Kwan P.W., Damassa D. Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. Journal of the National Cancer Institute 1988, 80:1045-1053.
63. Lee F., Torp-Pedersen S.T., Siders D.B., Littrup P.J., McLeary.R.D. Transrectal ultrsound in the diagnosis and staging of prostatic carcinoma. Radiology 1989, 170:609-615.
64. Li X., Rahman N. Estrogens and bladder outlet obstruction. Journal of Steroid Biochemistry and Molecuar Biology 2010, 118:257-263.
65. Lowsley O.S. The development of the human prostate gland with reference to the development of other structures at the neck of the urinary bladder. American Journal of Anatomy 1912, 13.
66. Lucia M.S., Lambert J.R. Growth factors in benign prostatic hyperplasia: basic science implications. Current Urology Reports 2008, 9:272-278.
67. le Maire A., Bourguet W., Balaguer P. A structural view of nuclear hormone receptor: endocrine disrup tor interactions. Cell and Molecular Life Sciences 2010, 67:1219-1237.
68. Mao P., Nakao K., Angrist A. Human prostatic carcinoma: an electron microscope study. Cancer Research 1966, 26:955-973.
69. Marker P.C., Donjacour A.A., Dahiya R., Cunha G.R. Hormonal, cellular, and molecular control of prostatic development. Developmental Biology 2003, 253:165-174.
70. McNeal J.E. Regional morphology and pathology of the prostate. Ameriacn Journal of Clinical Pathology 1968, 49:347-357.
71. McNeal J.E. The prostate and prostatic urethra: a morphological sysnthesis. Journal of Urology 1972, 107:1008-1016.
72. McNeal J.E. Origin and evolution of benign prostatic enlargement. Investigative Urology 1978, 15:340-345.
73. McNeal J.E. Anatomy of the prostate: an historical survey of divergent views. Prostate 1980, 1:3-13.
74. McNeal J.E. The prostate gland: morphology and pathobiology. Monographs in Urol 1983, 4:3-33.
75. Michaud E.J., Yoder B.K. The primary cilium in cell signaling and cancer. Cancer Research 2006, 66:6463-6467.
76. Mongiu A.K., McVary K.T. Lower urinary tract symptoms, benign prostatic hyperplasia, and obesity. Current Urology Reports 2009, 10:247-253.
77. Morgagni G. Translation of De sedibus et causis morborum 1769, Facsimile of the London, London.
78. Moser J.J., Fritzler M.J., Rattner J.B. Primary ciliogenesis defects are associated with human astrocytoma/glioblastoma cells. BMC Cancer 2009, 9:448.
79. Moul S., McVary K.T. Lower urinary tract symptoms, obesity and the metabolic syndrome. Current Opinion in Urology 2010, 20:7-12.
80. Nandeesha H., Koner B.C., Dorairajan L.N., Sen S.K. Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia. Clinica Chimica Acta 2006, 370:89-93.
81. O'Malley K.J., Dhir R., Nelson J.B., Bost J., Lin Y., Wang Z. The expression of androgen-responsive genes is up-regulated in the epithelia of benign prostatic hyperplasia. Prostate 2009, 69:1716-1723.
82. Oesterling J.E. The origin and development of benign prostatic hyperplasia. An age-dependent process. Journal of Andrology 1991, 12:348-355.
83. Oesterling J.E. Benign prostatic hyperplasia: a review of its histogenesis and natural history. Prostate 1996, 6:67-73. Suppl.
84. Ohtsuki Y., Seman G., Maruyama K., Bowen J.M., Johnson D.E., Dmochowski L. Ultrastructural studies of human prostatic neoplasia. Cancer 1976, 37:2295-2305.
85. Orr B., Grace O.C., Vanpoucke G., Ashley G.R., Thomson A.A. A role for notch signaling in stromal survival and differentiation during prostate development. Endocrinology 2009, 150:463-472.
86. Pallin G. Beiträge zur anatomie und embryologie der prostate und der samenblasen. Archive Anatomic Physiologie und Entwickelungegeschichte 1901, 135-176.
87. Pan J. Cilia and ciliopathies: from Chlamydomonas and beyond. Science China C Life Sciences 2008, 51:479-486.
88. Parsons J.K. Lifestyle factors, benign prostatic hyperplasia, and lower urinary tract symptoms. Current Opinion in urology 2011, 21:1-4.
89. Parsons J.K., Sarma A.V., McVary K., Wei J.T. Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. The Journal of Urology 2009, 182:S27-31.
90. Plotnikova O.V., Golemis E.A., Pugacheva E.N. Cell cycle-dependent ciliogenesis and cancer. Cancer Research 2008, 68:2058-2061.
91. Poole C.A., Zhang Z.J., Ross J.M. The differential distribution of acetylated and detyrosinated alpha-tubulin in the microtubular cytoskeleton and primary cilia of hyaline cartilage chondrocytes. Journal of Anatomy 2001, 199:393-405.
92. Price D. Comparative aspects of development and structure in the prostate. National Cancer Institute Monograph 1963, 12:1-27.
93. Prins G.S., Korach K.S. The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 2008, 73:233-244.
94. Ranjan P., Dalela D., Sankhwar S.N. Diet and benign prostatic hyperplasia: implications for prevention. Urology 2006, 68:470-476.
95. Reischauer F. Die entstehung der sogenannten prostatahypertrophie. Virchows Archiv fur Pathologie und Anatomie Physiolgie 1925, 256:357-389.
96. Riolan J., Anatomica Opera Vetera; recognita and auctiora. Lutetiae Parisiorum 1649.
97. Risbridger G.P., Almahbobi G.A., Taylor R.A. Early prostate development and its association with late-life prostate disease. Cell and Tissue Research 2005, 322:173-181.
98. Robert G., Descazeaud A., de la Taille A. Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: who are the high-risk patients and what are the best treatment options?. Current Opinions in Urology 2011, 21:42-48.
99. Roehrborn C.G. Pathology of benign prostatic hyperplasia. International Journal of Impotence Research 2008, 20(Suppl. 3):S11-18.
100. Roehrborn C.G. Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Medical Clinics of North America 2011, 95:87-100.
101. Rohatgi R., Scott M.P. Cell biology. Arrestin' movement in cilia. Science 2008, 320:1726-1727.
102. Rossi M., Roumeguere T. Silodosin in the treatment of benign prostatic hyperplasia. Jouranl of Drug Design, Development and Therapy 2010, 4:291-297.
103. Royuela M., de Miguel M.P., Bethencourt F.R., Sanchez-Chapado M., Fraile B., Arenas M.I., Paniagua R. Estrogen receptors alpha and beta in the normal, hyperplastic and carcinomatous human prostate. Journal of Endocrinology 2001, 168:447-454.
104. Satir P., Christensen S.T. Overview of structure and function of mammalian cilia. Annual Review of Physiology 2007, 69:377-400.
105. Saylor P.J., Smith M.R. Adverse effects of androgen deprivation therapy: defining the problem and promoting health among men with prostate cancer. Journal of National Comprehensive Cancer Network 2010, 8:211-223.
106. Schauer I.G., Ressler S.J., Tuxhorn J.A., Dang T.D., Rowley D.R. Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia. Urology 2008, 72:205-213.
107. Shapiro E. Embryologic development of the prostate. Urologic. Clinics of North America 1990, 17:487-491.
108. Shaw A., Bushman W. Hedgehog signaling in the prostate. The Journal of Urology 2007, 177:832-838.
109. Simpson F., Kerr M.C., Wicking C. Trafficking, development and Hedgehog. Mechanisms of Development 2009, 126:279-288.
110. Stanton B.Z., Peng L.F. Small-molecule modulators of the Sonic Hedgehog signaling pathway. Molecular Biosystems 2010, 6:44-54.
111. Sugimura Y., Norman J.T., Cunha G.R., Shannon J.M. Regional differences in the inductive activity of the mesenchyme of the embryonic mouse urogenital sinus. The Prostate (New York) 1985, 7:253-260.
112. Suzuki K., Matsui H., Hasumi M., Ono Y., Nakazato H., Koike H., Ito K., Fukabori Y., Kurokawa K., Yamanaka H. Gene expression profiles in human BPH: utilization of laser-capture microdissection and quantitative real-time PCR. Anticancer Research 2001, 21:3861-3864.
113. Taylor M.D., Liu L., Raffel C., Hui C.C., Mainprize T.G., Zhang X., Agatep R., Chiappa S., Gao L., Lowrance A., Hao A., Goldstein A.M., Stavrou T., Scherer S.W., Dura W.T., Wainwright B., Squire J.A., Rutka J.T., Hogg D. Mutations in SUFU predispose to medulloblastoma. Nature Genetics 2002, 31:306-310.
114. Teglund S., Toftgard R. Hedgehog beyond medulloblastoma and basal cell carcinoma. Biochimica et Biophysica Acta 2010, 1805:181-208.
115. Thoma C.R., Frew I.J., Krek W. The VHL tumor suppressor: riding tandem with GSK3beta in primary cilium maintenance. Cell Cycle 2007, 6:1809-1813.
116. Thompson H. The Diseases of the Prostate: Their Pathology and Treatment 1868, John Churchill and Sons, London.
117. Thomson A.A., Timms B.G., Barton L., Cunha G.R., Grace O.C. The role of smooth muscle in regulating prostatic induction. Development 2002, 129:1905-1912.
118. Thomson A.A., Cunha G.R., Marker P.C. Prostate development and pathogenesis. Differentiation 2008, 76:559-564.
119. Timms, B.G., 1980. Ultrastructure and Analytical Studies on the Rat Prostate, Tenovus Institute for Cancer Research, Welsh National School of Medicine, University of Wales, Cardiff, p. 170.
120. Timms B.G. Prostate development: a historical perspective. Differentiation (Heidelberg) 2008, 76:565-577.
121. Timms B.G., Chandler J.A. Ultrastructural and analytical studies on the prostate of castrated rats. The Prostate (New York) 1983, 4:37-55.
122. Timms B.G., Chandler J.A., Sinowatz F. The ultrastructure of basal cells of rat and dog prostate. Cell Tissue Research 1976, 173:543-554.
123. Timms B.G., Mohs T.J., DiDio L.J.A. Ductal budding and branching patterns in the developing prostate. Journal of Urology 1994, 151:1427-1432.
124. Timms B.G., Lee C.W., Aumuller G., Seitz J. Instructive Induction of prostate growth and differentiation by a defined urogenital sinus mesenchyme. Microscopy Research and Technique 1995, 30:319-332.
125. Timms B.G., Howdeshell K.L., Barton L., Bradley S., Richter C.A., vom Saal F.S. Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proceedings of the National Acadamy of Sciences USA 2005, 102:7014-7019.
126. Toftgard R. Two sides to cilia in cancer. Nature Medicine 2009, 15:994-996.
127. Veland I.R., Awan A., Pedersen L.B., Yoder B.K., Christensen S.T. Primary cilia and signaling pathways in mammalian development, health and disease. Nephron Physiology 2009, 111:p39-53.
128. Vezina C.M., Bushman A.W. Hedgehog signaling in prostate growth and benign prostate hyperplasia. Current Urology Reports 2007, 8:275-280.
129. Vikram A., Jena G. Role of insulin and testosterone in prostatic growth: who is doing what?. Medical Hypotheses 2011, 76:474-478.
130. Vikram A., Jena G., Ramarao P. Insulin-resistance and benign prostatic hyperplasia: the connection. European Journal of Pharmacology 2010, 641:75-81.
131. Vikram A., Jena G.B., Ramarao P. Increased cell proliferation and contractility of prostate in insulin resistant rats: linking hyperinsulinemia with benign prostate hyperplasia. The Prostate 2010, 70:79-89.
132. Vom Saal F.S., Timms B.G., Montano M.M., Palanza P., Thayer K.A., Nagel S.C., Dhar M.D., Ganjam V.K., Parmigiani S., Welshons W.V. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proceedings of the National Acadamy of Sciences USA 1997, 94:2056-2061.
133. Wang B.E., Shou J., Ross S., Koeppen H., De Sauvage F.J., Gao W.Q. Inhibition of epithelial ductal branching in the prostate by sonic hedgehog is indirectly mediated by stromal cells. The Journal of Biological Chemistry 2003, 278:18506-18513.
134. Wang Z., Olumi A.F. Diabetes, growth hormone-insulin-like growth factor pathways and association to benign prostatic hyperplasia. Differentiation 2011.
135. Wiesener M.S., Maxwell P.H., Eckardt K.U. Novel insights into the role of the tumor suppressor von Hippel Lindau in cellular differentiation, ciliary biology, and cyst repression. Journal of Molecular Medicine 2009, 87:871-877.
136. Wilson J.D., Roehrborn C. Long-term consequences of castration in men: lessons from the Skoptzy and the eunuchs of the Chinese and Ottoman courts. Journal of Clinical Endocrinol Metab 1999, 84:4324-4331.
137. Wong S.Y., Lau W.W., Leung P.C., Leung J.C., Woo J. The association between isoflavone and lower urinary tract symptoms in elderly men. British Journal of Nutrition 2007, 98:1237-1242.
138. Wong S.Y., Seol A.D., So P.L., Ermilov A.N., Bichakjian C.K., Epstein E.H., Dlugosz A.A., Reiter J.F. Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nature Medicine 2009, 15:1055-1061.
139. Wong S.Y., Seol A.D., So P.L., Ermilov A.N., Bichakjian C.K., Epstein E.H., Dlugosz A.A., Reiter J.F. Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nature Medicine 2009, 15:1055-1061.
140. Wu Q., Shi J., Chen L., Wang C.Y., Park I., Lee C., Zhang J. Regulation of proliferation and differentiation of prostatic stromal cells by oestradiol through prostatic epithelial cells in a paracrine manner. BJU International 2008, 101:497-502.
141. Wu X., Xu K., Zhang L., Deng Y., Lee P., Shapiro E., Monaco M., Makarenkova H.P., Li J., Lepor H., Grishina I. Differentiation of the ductal epithelium and smooth muscle in the prostate gland are regulated by the Notch/PTEN-dependent mechanism. Developmental Biology 2011, 10.1016/j.ydbio.2011.05.659.
142. Zhang J., Lipinski R.J., Gipp J.J., Shaw A.K., Bushman W. Hedgehog pathway responsiveness correlates with the presence of primary cilia on prostate stromal cells, BMC. Developmental Biology 2009, 9:50.
143. Zhu C., Zhao J., Bibikova M., Leverson J.D., Bossy-Wetzel E., Fan J.B., Abraham R.T., Jiang W. Functional analysis of human microtubule-based motor proteins, the kinesins and dyneins, in mitosis/cytokinesis using RNA interference. Molecular Biology of Cell 2005, 16:3187-3199.
144. Zuckerman S. The endocrine control of the prostate: (Section of Urology). Proceedings of the Royal Society of Medicine 1936, 29:1557-1568.